Archive for: idiopathic

Daewoong Pharmaceutical begins the first administration of the Bersiporocin, new treatment for idiopathic pulmonary fibrosis, as Phase II clinical trial

 
 

Europe Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, Shionogi & Co, AstraZeneca & Others